Research & Development

噜噜吧噜噜色噜噜一个俄罗斯人说现在是国家最好的时候 因为稳定

發布時間︰

  酒過八巡之後,朱買臣按著酒壺道︰“陛下來了?”   衛青從來都是撿別人的便宜,哪有多余的便宜讓別人撿。噜噜吧   下一刻,霍去病就帶著受降城里的所有軍卒就來到了白狼口,到了白狼口,連休息一下的意思都沒有,就一頭扎進了荒原。噜噜色   黑色的草原還在冒煙,雲瑯想在這片溫暖的土地上睡個覺的願望也遺憾的落空了。   霍去病掏出印信,燒軟了火漆,迅速的用了印信,他很想看雲瑯改動的那幾個字,文書卻被雲瑯抽走了,看他離去的方向,應該是去找何愁有了。噜噜   一隊隊彪悍的騎兵從他們的身邊掠過,追逐著遠去的野火。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo